S294: MARIBAVIR (MBV) VERSUS INVESTIGATOR-ASSIGNED THERAPY FOR REFRACTORY CYTOMEGALOVIRUS (CMV) INFECTION: SUBGROUPS ANALYSES OF PHASE 3 STUDY BY RESISTANCE STATUS KNOWLEDGE REPORTED BY INVESTIGATORS.

Detalles Bibliográficos
Autores principales: Duarte, Rafael F, Alain, Sophie, Chemaly, Roy F, Montoto, Carmen, de Castro-Orós, Isabel, Maertens, Johan, Tagarro, Ignacio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428459/
http://dx.doi.org/10.1097/01.HS9.0000968088.69924.4d

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428459/
http://dx.doi.org/10.1097/01.HS9.0000968088.69924.4d

Ejemplares similares